The scientist’s investigation covers issues in Nanotechnology, Engineered nanomaterials, Nanotoxicology, In vitro and Nanoparticle. His work deals with themes such as Gastrointestinal tract, Food safety and Food packaging, which intersect with Nanotechnology. Philip Demokritou has included themes like Biomedical engineering and Biochemical engineering in his Engineered nanomaterials study.
His Nanotoxicology research incorporates elements of Screening assay, High-throughput screening, Dna breaks and Genotoxicity. His In vitro research incorporates themes from Monolayer, Biophysics, Inhalation exposure, Protein Corona and In vivo. His Nanoparticle research includes elements of Pathology, Size fractions, Albumin, Titanium dioxide and Blood–air barrier.
His scientific interests lie mostly in Nanotechnology, Engineered nanomaterials, Nanotoxicology, Nanoparticle and In vitro. His Nanotechnology study frequently draws connections to other fields, such as Food safety. While the research belongs to areas of Engineered nanomaterials, Philip Demokritou spends his time largely on the problem of Inhalation exposure, intersecting his research to questions surrounding Pharmacology and Oxidative stress.
His research on Nanotoxicology often connects related topics like Bioavailability. His study in the field of Protein Corona is also linked to topics like Occupational exposure. His research in In vitro intersects with topics in Cell culture, Biophysics, Toxicity and In vivo.
Philip Demokritou spends much of his time researching Nanomaterials, In vitro, Cytotoxicity, Nanotechnology and Engineered nanomaterials. His Nanomaterials study incorporates themes from Nanofiber, Carbon and Carbon nanotube. His In vitro research is multidisciplinary, incorporating perspectives in High-throughput screening and Toxicity, Genotoxicity.
Philip Demokritou combines subjects such as Inflammation, Digestion, Oxidative phosphorylation and Nanotoxicology with his study of Cytotoxicity. He is interested in Nanoparticle, which is a branch of Nanotechnology. The Engineered nanomaterials study combines topics in areas such as Structure–activity relationship and Inhalation exposure.
His primary areas of investigation include Nanotechnology, Engineered nanomaterials, Nanoparticle, Nanomaterials and In vitro. Philip Demokritou has researched Nanotechnology in several fields, including Biopolymer and Electrospinning. His study in Engineered nanomaterials is interdisciplinary in nature, drawing from both Machine learning and Inhalation exposure.
His Nanoparticle research is multidisciplinary, relying on both Colloid, Particle size and Trisodium citrate. His studies deal with areas such as Carbon, Protein Corona, Carbon nanotube and Artificial intelligence as well as Nanomaterials. His work deals with themes such as Food industry, Food additive, Toxicity and In vivo, which intersect with In vitro.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Measurements of PM10 and PM2.5 particle concentrations in Athens, Greece
A. Chaloulakou;P. Kassomenos;N. Spyrellis;Philip Demokritou.
Atmospheric Environment (2003)
A 10-year time-series analysis of respiratory and cardiovascular morbidity in Nicosia, Cyprus: the effect of short-term changes in air pollution and dust storms
Nicos Middleton;Panayiotis K. Yiallouros;Savvas Kleanthous;Ourania Kolokotroni.
Environmental Health (2008)
Estimating the effective density of engineered nanomaterials for in vitro dosimetry
Glen DeLoid;Joel M. Cohen;Tom Darrah;Raymond Derk.
Nature Communications (2014)
Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry
Joel Cohen;Glen DeLoid;Georgios Pyrgiotakis;Philip Demokritou.
An integrated approach for the in vitro dosimetry of engineered nanomaterials.
Joel M Cohen;Justin G Teeguarden;Philip Demokritou.
Particle and Fibre Toxicology (2014)
Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials
Glen M DeLoid;Joel M Cohen;Georgios Pyrgiotakis;Philip Demokritou.
Nature Protocols (2017)
An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO2 inhalation exposures
Philip Demokritou;Samuel Gass;Georgios Pyrgiotakis;Joel M. Cohen.
High-Throughput Screening Platform for Engineered Nanoparticle-Mediated Genotoxicity Using CometChip Technology
Christa Watson;Jing Ge;Joel Cohen;Georgios Pyrgiotakis.
ACS Nano (2014)
Nanotechnology for sustainable food production: promising opportunities and scientific challenges
Sónia M. Rodrigues;Philip Demokritou;Nick Dokoozlian;Christine Ogilvie Hendren.
Environmental science. Nano (2017)
Advanced computational modeling for in vitro nanomaterial dosimetry.
Glen M. DeLoid;Joel M. Cohen;Georgios Pyrgiotakis;Sandra V. Pirela.
Particle and Fibre Toxicology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: